{
    "clinical_study": {
        "@rank": "95874", 
        "arm_group": [
            {
                "arm_group_label": "ACB with 30 ml lidocaine 1%", 
                "arm_group_type": "Experimental", 
                "description": "Procedure/Surgery:   Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively  for every new cohort (2 subjects) in the study.\nPossible dose levels are: 5, 10, 15, 20, 25 and 30 ml."
            }, 
            {
                "arm_group_label": "ACB with 25 ml lidocaine 1%", 
                "arm_group_type": "Experimental", 
                "description": "Procedure/Surgery:   Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively  for every new cohort (2 subjects) in the study.\nPossible dose levels are: 5, 10, 15, 20, 25 and 30 ml."
            }, 
            {
                "arm_group_label": "ACB with 20 ml lidocaine 1%", 
                "arm_group_type": "Experimental", 
                "description": "Procedure/Surgery:   Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively  for every new cohort (2 subjects) in the study.\nPossible dose levels are: 5, 10, 15, 20, 25 and 30 ml."
            }, 
            {
                "arm_group_label": "ACB with 15 ml lidocaine 1%", 
                "arm_group_type": "Experimental", 
                "description": "Procedure/Surgery:   Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively  for every new cohort (2 subjects) in the study.\nPossible dose levels are: 5, 10, 15, 20, 25 and 30 ml."
            }, 
            {
                "arm_group_label": "ACB with 10 ml lidocaine 1%", 
                "arm_group_type": "Experimental", 
                "description": "Procedure/Surgery:   Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively  for every new cohort (2 subjects) in the study.\nPossible dose levels are: 5, 10, 15, 20, 25 and 30 ml."
            }, 
            {
                "arm_group_label": "ACB with 5 ml lidocaine 1%", 
                "arm_group_type": "Experimental", 
                "description": "Procedure/Surgery:   Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively  for every new cohort (2 subjects) in the study.\nPossible dose levels are: 5, 10, 15, 20, 25 and 30 ml."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this prospective dose finding study is to estimate the minimal effective volume\n      (ED95) for lidocaine 1.0% for filling the adductor canal when placing an adductor canal\n      block. We will apply the Continual Reassessment Method (CRM) for estimating the ED95 and use\n      an MRI scan to evaluate the main objective and ensure spread to the distal part of the\n      adductor canal."
        }, 
        "brief_title": "ED95 of Lidocaine 1.0% for Filling the Adductor Canal", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-30 years\n\n          -  Men\n\n          -  American Society of Anesthesiologists' class 1\n\n          -  Body Mass Index 18-25\n\n        Exclusion Criteria:\n\n          -  Allergy to study medication\n\n          -  Earlier trauma or surgery to the lower limb\n\n          -  Diabetes Mellitus - Contraindications to MRI"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033356", 
            "org_study_id": "SM3-PJ-13", 
            "secondary_id": "2013-004462-33"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "ACB with 30 ml lidocaine 1%", 
                    "ACB with 25 ml lidocaine 1%", 
                    "ACB with 20 ml lidocaine 1%", 
                    "ACB with 15 ml lidocaine 1%", 
                    "ACB with 10 ml lidocaine 1%", 
                    "ACB with 5 ml lidocaine 1%"
                ], 
                "description": "US-guided adductor canal block", 
                "intervention_name": "Adductor canal block with lidocaine 1%", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "ACB with 30 ml lidocaine 1%", 
                    "ACB with 25 ml lidocaine 1%", 
                    "ACB with 20 ml lidocaine 1%", 
                    "ACB with 15 ml lidocaine 1%", 
                    "ACB with 10 ml lidocaine 1%", 
                    "ACB with 5 ml lidocaine 1%"
                ], 
                "intervention_name": "Lidocaine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Lidocaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "adductor canal block", 
            "volunteers", 
            "US-guided peripheral nerve block", 
            "lower limb", 
            "MRI"
        ], 
        "lastchanged_date": "April 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00f8borg", 
                    "country": "Denmark", 
                    "zip": "2860"
                }, 
                "name": "Aleris-Hamlet Hospitals Copenhagen"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "6", 
        "official_title": "An Estimate of the ED95 of Lidocaine 1.0% for Filling the Adductor Canal When Placing an Adductor Canal Block in Healthy Volunteers", 
        "overall_official": {
            "affiliation": "Department of Anaesthesia, HOC, Rigshospitalet, Denmark", 
            "last_name": "Pia Jaeger, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Medicines Agency", 
                "Denmark: The Regional Committee on Biomedical Research Ethics", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "This will be evaluated as a binary outcome using MRI; where the adductor canal is considered to be filled if the lidocaine injectate can be identified inside the canal in the first slice distally to the insertion of the adductor longus muscle on femur.", 
            "measure": "To estimate the ED 95 for the volume needed to fill the adductor canal distally.", 
            "safety_issue": "No", 
            "time_frame": "MRI performed 15 minutes post block"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033356"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Pia Jaeger", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluated as a binary outcome using MRI", 
                "measure": "To investigate the effect of volume on proximal spread to the femoral triangle", 
                "safety_issue": "No", 
                "time_frame": "MRI performed 15 minutes post block"
            }, 
            {
                "description": "To investigate the effect of volume on quadriceps muscle strength, assessed as maximum voluntary isometric contraction (MVIC)  and evaluated as a binary outcome (reduction by more or less than 25%).", 
                "measure": "Quadriceps muscle strength", 
                "safety_issue": "No", 
                "time_frame": "1 hour post block"
            }, 
            {
                "description": "To investigate the effect of volume on sensory block assessed by pin-prick in the saphenous innervation area and in the popliteal fossa.", 
                "measure": "Pin prick test", 
                "safety_issue": "No", 
                "time_frame": "1 hour post block"
            }, 
            {
                "description": "To investigate the effect of volume on sensory block assessed by cold sensation using alchohol swabs, in the saphenous innervation area and in the popliteal fossa.", 
                "measure": "Temperature discrimination test", 
                "safety_issue": "No", 
                "time_frame": "1 hour post block"
            }
        ], 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}